ADC Therapeutics (ADCT)
(Delayed Data from NYSE)
$2.87 USD
-0.01 (-0.35%)
Updated Aug 5, 2024 04:00 PM ET
After-Market: $2.86 -0.01 (-0.35%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth B Momentum D VGM
Earnings News For ADCT
-
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates
-
ADC Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
-
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
-
ADC Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
-
Earnings Preview: ADC Therapeutics SA (ADCT) Q4 Earnings Expected to Decline
-
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Lags Revenue Estimates
-
ADC Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
-
ADC Therapeutics SA (ADCT) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
-
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
-
ADC Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Updates
-
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Misses Revenue Estimates
-
ADC Therapeutics Reports First Quarter 2023 Financial Results and Provides Business and Strategy Update
-
Analysts Estimate ADC Therapeutics SA (ADCT) to Report a Decline in Earnings: What to Look Out for
-
ADC Therapeutics Releases its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2022
-
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Misses Revenue Estimates
-
ADC Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
-
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates
-
ADC Therapeutics Reports Third Quarter 2022 Financial Results and Provides Business Updates
-
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Lags Revenue Estimates
-
ADC Therapeutics SA (ADCT) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
ADC Therapeutics SA (ADCT) Reports Q1 Loss, Tops Revenue Estimates
-
ADC Therapeutics SA (ADCT) Reports Q4 Loss, Tops Revenue Estimates
-
ADC Therapeutics SA (ADCT) Reports Q3 Loss, Tops Revenue Estimates
-
ADC Therapeutics SA (ADCT) Reports Q2 Loss, Misses Revenue Estimates